LATAM OTC Results Round-Up: Mexico's Genomma Lab, Brazil's Hypera
Genomma enjoys broad-based growth in 2018, while NPD investments pay off for Hypera.
You may also be interested in...
Sanofi Consumer Healthcare is utilizing emerging digital technology to take a bigger slice of the Latin American OTC market. Through a partnership deal, e-commerce and delivery firm Rappi will promote and sell Sanofi's brands to consumers across seven Latin American markets.
A clinical trial will explore the effectiveness of OTC ibuprofen drug Flarin in reducing COVID-19 related respiratory failure in hospitalized patients, following "compelling" pre-clinical data.
EU Business Round-Up: Stada Enters Germany Top-5, Dr Wolff Takes Vagisan To Poland, Fidia And Sanova Strike Nasal Spray Deals
Acquiring six brands from GSK has propelled Stada into Germany's OTC top-5; Dr. Wolff has secured distribution for its Vagisan women's health brand in Poland; and Sanova and Fidia have added innovative nasal sprays to their respective portfolios.